Abstracts

Call for abstracts

We are delighted to invite you to submit abstracts for NordCoag 2026.

Submissions across all areas of hemostasis and thrombosis are welcome — from basic science and translational research to clinical studies and laboratory innovations. We particularly encourage abstracts that highlight Nordic collaborations, novel diagnostic approaches, emerging therapies, and quality improvements in laboratories.

Abstracts will be presented as posters, offering excellent opportunities for networking and knowledge exchange among Nordic colleagues. Abstracts of particular scientific interest will be invited for presentation during the Guided Poster Walk, and an award will be presented for the best abstract.

Authors will be notified of acceptance or rejection of the abstract on 29 May. Sometimes, important emails might mistakenly end up in your spam folder. To ensure you don’t miss out on important information, please review your spam folder regularly.

We look forward to your contributions!

Abstract Committee NordCoag 2026:

Andries Blokzijl, Margareta Holmström and David Schmidt

Important dates:

  • Call for abstracts opens: 30 January
  • Deadline for abstracts: 30 April
  • Notification of acceptance: 29 May

Abstracts can be submitted through the abstract submission form once the it opens on 30 January 2026.

Ensure that your abstract adheres to the following guidelines:

AUTHORS and AFFILIATIONS: Please underline the presenting author.

TITLE: The title should be a maximum of 150 characters. Be concise and clear while summarizing the main focus of your research.

BACKGROUND AND AIMS: Present a short introduction to the study’s context and its objectives. Clearly state the hypothesis or research question your study addresses.

METHODS: Describe the research methods employed, including data collection, experiments, or analysis techniques. Do not withhold technical details that are essential to understand your approach. If applicable, add obtained ethical approval.

RESULTS: Provide a straightforward presentation of your study’s findings. Avoid vague phrases such as “results will be discussed.” Use precise language to convey your outcomes.

CONCLUSIONS: Summarize the key insights derived from your study and their implications. Ensure that the conclusion is clear, concise, and supported by the presented results.

Comply with the 300-word limit for the abstract body, exclusive of the title, author names, and affiliations. Author names and affiliations must be entered as specified in the abstract. All authors should have read and approved the final version of the abstract. The text should be clear, concise, and written in proper English.

If your abstract is accepted, the presenting author should print and bring their own poster to the congress.

Poster presenters should adhere to the following guidelines: 

  • Use a poster size of 84 cm x 119 cm (A0) in portrait orientation (the poster wall dimensions are 99 cm x 138 (W x H)) 
  • Keep the amount of text to a minimum. 
  • For optimal visibility, use a font size of 32 points or larger. 
  • Use images, graphs, and tables as needed. 
  • Ensure that the content on your poster follows a logical sequence. 

A printing service is not available. Please note that electronic versions of the posters will not be provided. The congress organisers will supply pins for mounting the posters onto the poster wall.

An abstract award is given by a committee to the highest-ranking abstract submitted to NordCoag 2026. The award is to recognize outstanding scientific work and innovative work as well as dedication of our participants.

Travel awards cannot be provided by this conference.

Authors are allowed to use their own material for educational purposes, as well as posting to the author’s website.

Please note that the presenting author is required to register as a congress delegate for poster presentation at the congress. You may be the presenting author on one poster only, but you can be co-author on several abstracts.

Upon submission, the submitting author verifies that all co-authors have approved of the content of the abstract. The submitting author will serve as corresponding author and is responsible for informing the co-authors about the status of the abstract.